These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hypersensitivity to polyethylene glycol (PEG). Czarnobilska M; Bulanda M; Kurnik-Łucka M; Gil K Folia Med Cracov; 2021 Dec; 61(4):55-69. PubMed ID: 35180202 [TBL] [Abstract][Full Text] [Related]
47. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity. Zarnegar-Lumley S; Stone CA; Smith CM; Hall LL; Luck KE; Koo G; Plager JH; Phillips EJ; Friedman DL Pediatr Blood Cancer; 2022 Jul; 69(7):e29686. PubMed ID: 35353440 [TBL] [Abstract][Full Text] [Related]
48. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data. Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939 [TBL] [Abstract][Full Text] [Related]
49. Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease. Algaba A; Romero S; Granja A; Garza D; Aller M; Barrero S; Guerra I; Gil M; Pizarro N; Ruiz P; Prieto S; Hernández B; Pou A; Bermejo F Gastroenterol Hepatol; 2023 Jan; 46(1):48-53. PubMed ID: 35605819 [TBL] [Abstract][Full Text] [Related]
51. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation. Erdeljic Turk V Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618 [TBL] [Abstract][Full Text] [Related]
52. Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine. Maron JS; Conroy M; Naranbai V; Samarakoon U; Motazedi T; Farmer JR; Freeman E; Banerji A; Bartsch YC; Gregory DJ; Poznansky MC; Alter G; Blumenthal KG J Infect Dis; 2022 Sep; 226(7):1231-1236. PubMed ID: 35325158 [TBL] [Abstract][Full Text] [Related]
53. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. Nakashima C; Kato M; Otsuka A J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825 [TBL] [Abstract][Full Text] [Related]
54. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers. Maruyama A; Sawa T; Teramukai S; Katoh N J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536 [TBL] [Abstract][Full Text] [Related]
55. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Yang S; Li Y; Dai L; Wang J; He P; Li C; Fang X; Wang C; Zhao X; Huang E; Wu C; Zhong Z; Wang F; Duan X; Tian S; Wu L; Liu Y; Luo Y; Chen Z; Li F; Li J; Yu X; Ren H; Liu L; Meng S; Yan J; Hu Z; Gao L; Gao GF Lancet Infect Dis; 2021 Aug; 21(8):1107-1119. PubMed ID: 33773111 [TBL] [Abstract][Full Text] [Related]
56. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions. Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275 [TBL] [Abstract][Full Text] [Related]
57. Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders. Zhu CK; Nguyen A; Prosty C; Gabrielli S; Mulé P; Netchiporouk E; Le M; Zhang X; Shand G; Baum S; Hakroush R; Greenberger S; Ollech A; Miedzybrodzki B; Ben-Shoshan M Clin Exp Med; 2023 Dec; 23(8):4937-4942. PubMed ID: 37837561 [TBL] [Abstract][Full Text] [Related]
58. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance. Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A Front Immunol; 2022; 13():956825. PubMed ID: 36177033 [TBL] [Abstract][Full Text] [Related]
59. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose. AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM Front Allergy; 2022; 3():825164. PubMed ID: 35386647 [TBL] [Abstract][Full Text] [Related]
60. CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience. Gumusburun R; Dalgıc CT; Mete Gokmen EN; Sin AZ Int Arch Allergy Immunol; 2022; 183(7):778-784. PubMed ID: 35462361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]